Patients with Severe RSV Outcomes
Overall, 77 (19.1%) of the 403 patients experienced severe illness including 66 (16.4%) who were admitted to an ICU, 50 (12.4%) who received mechanical ventilation, and/or 27 (6.7%) who died during hospitalization. The median length of ICU stay was seven days (IQR 3.5 to 12 days) and the median duration of mechanical ventilation was three days (IQR 2 to 9.5 days).
The number of patients hospitalized with laboratory-confirmed RSV infection ranged from 4-92 each month and the number of patients with severe illness ranged from 0-21 each month (Figure 1). Both surveillance years, the number of patients hospitalized with RSV infection was highest in December and January. The proportion of patients with severe RSV outcomes each year and each month were similar.